Triptan

Triptan

Sumatriptan

Triptans are a class of medications used primarily in the treatment of migraines and cluster headaches. They are selective serotonin receptor agonists that act on the 5-HT_1B and 5-HT_1D receptors. Triptans are effective in alleviating the symptoms of migraines, including headache, nausea, and sensitivity to light and sound.

Mechanism of Action

Triptans work by stimulating the 5-HT_1B and 5-HT_1D receptors, which are subtypes of the serotonin receptor. This action leads to the constriction of dilated blood vessels in the brain, which is believed to be a primary cause of migraine headaches. Additionally, triptans inhibit the release of pro-inflammatory neuropeptides, further reducing migraine symptoms.

Pharmacokinetics

Triptans vary in their pharmacokinetic properties, including their onset of action, half-life, and bioavailability. For example, sumatriptan has a rapid onset but a short half-life, making it suitable for acute migraine attacks. In contrast, frovatriptan has a longer half-life, which may be beneficial for prolonged migraine episodes.

Common Triptans

Rizatriptan

Several triptans are available, each with unique properties:

• Sumatriptan - The first triptan developed, available in various forms including tablets, nasal sprays, and injections.
• Rizatriptan - Known for its rapid onset of action, often used in orally disintegrating tablet form.
• Naratriptan - Has a longer half-life, providing sustained relief.
• Eletriptan - Offers a balance between rapid onset and duration of action.
• Almotriptan - Known for its high tolerability and efficacy.
• Frovatriptan - Notable for its long half-life, useful for menstrual migraines.
• Zolmitriptan - Available in nasal spray and orally disintegrating tablet forms.

Side Effects

Common side effects of triptans include dizziness, fatigue, dry mouth, and sensations of tingling or warmth. Rarely, they can cause more serious cardiovascular effects, such as chest pain or tightness, due to their vasoconstrictive properties. Patients with a history of cardiovascular disease should use triptans with caution.

Contraindications

Triptans are contraindicated in individuals with a history of ischemic heart disease, cerebrovascular disease, or uncontrolled hypertension. They should not be used in combination with monoamine oxidase inhibitors (MAOIs) or within 24 hours of using another triptan or ergotamine-containing medication.

Related Pages

• Migraine
• Serotonin receptor
• Cluster headache
• Vasoconstriction